Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

Non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins

US Patent 10611827 · Granted Apr 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic composition comprising a fusion peptide derived from superantigen to2023
Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and Lu2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Immunogenic composition comprising a fusion peptide derived from superantigen to2022
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fus2021
Modified ebolavirus glycoproteins comprising mutations in the head and base doma2021
Modified ebolavirus glycoproteins comprising mutations in the head and base doma2021
Targeting immunological functions to the site of bacterial infections using cell2021
Targeting immunological functions to the site of bacterial infections using cell2019